Skip to content

Are You Prepared For Questions About Medical Cannabis?

Are You Prepared For Questions About Medical Cannabis?

With over 85% of Americans supporting legalizing medical cannabis, it’s inevitable that patients will begin asking their primary care doctors about its use and overall efficacy. Doctors and other medical professionals will be called upon to be ‘sense-makers’ for a treatment they never studied in medical school and have limited available research to draw upon.  It’s a very challenging problem made more complex by the fact that medical cannabis use in individuals 65 and older increased 75% in the last 4 years, leaving many to wonder if there are any negative effects resulting from interactions with other medications. 

We at Arfinn Med understand the complexity of this issue and have released an updated version of our software to address this gap.  In addition to our EMR, completely online patient intake process, and telehealth solutions, we now have the ability to track patient outcomes dynamically through SMS updates, a customizable patient portal, and data fields specifically for cannabis patients.  This information will help medical professionals assist their patients throughout the whole process including efficacy review data on dispensaries and product type.     

We will also allow medical professionals with split practices to embed our platform in their existing EMR software so they can query our database of deidentified efficacy data for any patient demographic or condition. This will allow our users to confidently recommend cannabis to their patients with actual point-of-care analytics while keeping cannabis patients separate from the general patient population.  This will ensure cannabis patients will receive the proper follow-up and monitoring. 

If you’re looking for easy to use practice management software and a robust EMR, please reach out to us at to learn how we put the power of data into your patient care.      

Stories you may be interested in

Substance in cannabis ‘could boost pancreatic cancer treatments’

A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More

Medical Marijuana a Hit With Seniors

In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers. Nine out of 10 liked it so much they said they’d recommend medical pot to others. “I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you,” said one senior. Another patient put…
Read More

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

Report of the Guideline Development Subcommittee of the American Academy of Neurology:   We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More

After marijuana edibles helped dying Holocaust survivor battle Alzheimer’s, his family’s foundation pushes for more research

A Massachusetts family’s experience giving marijuana edibles to their dying patriarch is set to kick off a desperately needed investigation into how cannabis might treat some of the more troubling symptoms of Alzheimer’s disease, a condition that affects 5.7 million Americans. Read the full story here.
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More

Leave a Comment

You must be logged in to post a comment.